Sonnet BioTherapeutics Holdings, Inc.
SONN
$3.47
$0.092.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 321.30K | 2.06M | 4.86M | 149.50K | 3.55M |
| Total Receivables | 597.40K | 778.20K | 666.80K | 762.10K | 519.60K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 400.90K | 420.70K | 1.20M | 1.21M | 1.05M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.32M | 3.26M | 6.73M | 2.12M | 5.13M |
|
|
|||||
| Total Current Assets | 1.32M | 3.26M | 6.73M | 2.12M | 5.13M |
| Net Property, Plant & Equipment | 77.50K | 99.70K | 121.70K | 143.90K | 165.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 658.30K | 478.60K | 335.10K | 509.10K | 503.50K |
| Total Assets | 2.06M | 3.84M | 7.18M | 2.77M | 5.80M |
|
|
|||||
| Total Accounts Payable | 3.75M | 1.75M | 1.64M | 2.18M | 1.88M |
| Total Accrued Expenses | 1.28M | 1.34M | 1.39M | 940.70K | 1.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 68.80K | 90.40K | 87.30K | 84.30K | 81.30K |
| Total Finance Division Other Current Liabilities | 2.00K | 1.70K | 1.70K | 1.80K | 2.60K |
| Total Other Current Liabilities | 2.00K | 1.70K | 1.70K | 1.80K | 2.60K |
| Total Current Liabilities | 5.10M | 3.17M | 3.12M | 3.21M | 3.11M |
|
|
|||||
| Total Current Liabilities | 5.10M | 3.17M | 3.12M | 3.21M | 3.11M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 23.60K | 46.60K | 68.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.10M | 3.17M | 3.15M | 3.26M | 3.18M |
|
|
|||||
| Common Stock & APIC | 125.06M | 125.00M | 124.88M | 117.20M | 117.17M |
| Retained Earnings | -128.11M | -124.33M | -120.84M | -117.68M | -114.55M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.05M | 662.30K | 4.04M | -485.70K | 2.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.05M | 662.30K | 4.04M | -485.70K | 2.62M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.05M | 662.30K | 4.04M | -485.70K | 2.62M |
|
|
|||||